Non-coding RNAs: emerging biomarkers and therapeutic targets in cancer and inflammatory diseases
Date
2025-03-10
Journal Title
Journal ISSN
Volume Title
Type
Article
Publisher
Frontiers Media SA
Series Info
Frontiers in Oncology ; Volume 15 , 2025 , Article number 1534862
Scientific Journal Rankings
Abstract
Non-coding RNAs (ncRNAs) have a significant role in gene regulation, especially in
cancer and inflammatory diseases. ncRNAs, such as microRNA, long non-coding
RNAs, and circular RNAs, alter the transcriptional, post-transcriptional, and
epigenetic gene expression levels. These molecules act as biomarkers and
possible therapeutic targets because aberrant ncRNA expression has been directly
connected to tumor progression, metastasis, and response to therapy in cancer
research. ncRNAs’ interactions with multiple cellular pathways, including MAPK, Wnt,
and PI3K/AKT/mTOR, impact cellular processes like proliferation, apoptosis, and
immune responses. The potential of RNA-based therapeutics, such as antimicroRNA and microRNA mimics, to restore normal gene expression is being
actively studied. Additionally, the tissue-specific expression patterns of ncRNAs
offer unique opportunities for targeted therapy. Specificity, stability, and immune
responses are obstacles to the therapeutic use of ncRNAs; however, novel strategies,
such as modified oligonucleotides and targeted delivery systems, are being
developed. ncRNA profiling may result in more individualized and successful
treatments as precision medicine advances, improving patient outcomes and
creating early diagnosis and monitoring opportunities. The current review aims to
investigate the roles of ncRNAs as potential biomarkers and therapeutic targets in
cancer and inflammatory diseases, focusing on their mechanisms in gene regulation
and their implications for non-invasive diagnostics and targeted therapies. A
comprehensive literature review was conducted using PubMed and Google
Scholar, focusing on research published between 2014 and 2025. Studies were
selected based on rigorous inclusion criteria, including peer-reviewed status and
relevance to ncRNA roles in cancer and inflammatory diseases. Non-English, nonpeer-reviewed, and inconclusive studies were excluded. This approach ensures that
the findings presented are based on high-quality and relevant sources
Description
Q2
Keywords
ncRNA, miRNA, lncRNA, circRNA, cancer, inflammation, biomarkers, therapy
Citation
Abdelmonem, B. H., Kamal, L. T., Wardy, L. W., Ragheb, M., Hanna, M. M., Elsharkawy, M., & Abdelnaser, A. (2025). Non-coding RNAs: emerging biomarkers and therapeutic targets in cancer and inflammatory diseases. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1534862